T-cell metabolic ageing as a factor for therapeutic research

Authors:

Abstract
Ageing is an important determinant of immune function across the lifespan, yet it remains underappreciated in the design and interpretation of much basic T-cell research. As the immune system ages, T-cell responses become less diverse, less efficient, and less adaptable, with consequences for infection control, vaccine responsiveness, cancer immunosurveillance, and the performance of T-cell-based immunotherapies. This issue is particularly acute because many fundamental studies still rely on T cells from, mostly, healthy young donors. These controls are indispensable, but the field has built much of its pre-clinical logic on immune systems that are younger, fitter, and biologically distinct from the patients for whom T-cell therapies are intended. We argue that this mismatch between experimental systems and clinical reality could be overcome by considering age as a routine variable from the start.
Funding Information
  • Medical Research Council Canada (MR/Z504269/1)

This publication has 33 references indexed in Scilit: